2019 - Stockholm - Sweden

2019 - Stockholm - Sweden

 

Tuesday

 

       
14:00-18:00 Registration at the conference venue
       
       
18:00-19:30 Welcome reception with drinks and light snacks (no dinner)
       

 

 

Wednesday

 

       
08:00-08:45 Registration at the conference venue
       
       
08:45-09:00 Welcome and introduction
       
       
09:00-09:45 Keynote lecture

Chair: Dinesh De Alwis

       
09:00-09:45 Jeff Sachs Pharmacometrics: A shot in the arm for vaccine discovery and development ~or~ Vaccines are not immune to the charms of pharmacometrics
       
09:45-09:50 PAGE scientific program

Siv Jonsson

       
09:50-11:15 Coffee break, poster and software session I: posters in Group I (with poster numbers starting with I-) are accompanied by their presenter
       
       
11:15-12:15 Infectious diseases

Chair: France Mentré

       
11:15-11:35 Marjorie Imperial Stratified medicine approaches for drug susceptible tuberculosis patients
       
11:35-11:55 Stefanie Hennig Repeated time-to-event models support that Pseudomonas aeruginosa infection increase the risk of acquiring Aspergillus in young children with cystic fibrosis
       
11:55-12:15 María García-Cremades Individual level data meta-analysis from HIV pre-exposure prophylaxis (PrEP) clinical trials
       
12:15-13:45 Lunch
       
       
13:45-14:30 Tutorial

Chair: Mats Karlsson

       
13:45-14:30 Nicky Best Use of informative priors in model-informed drug development
       
14:30-15:10 Machine learning in oncology

Chairs: Mats Karlsson, Paolo Magni

       
14:30-14:50 Chiara Nicolò Machine learning combined to mechanistic modeling of differential effects of neoadjuvant sunitinib on primary tumor and metastatic growth
       
14:50-15:10 Sebastien Benzekry Machine learning versus mechanistic modeling for prediction of metastatic relapse in breast cancer
       
15:10-16:40 Coffee break, poster and software session I: posters in Group II (with poster numbers starting with II-) are accompanied by their presenter
       
       
16:40-16:45 Clinical pharmacometrics - ISoP special interest group

Mirjam Trame and Eva Germovsek

       
16:45-17:25 Clinical applications

Chair: Oscar Della Pasqua

       
16:45-17:05 João Abrantes Bayesian forecasting utilizing bleeding information to support dose individualization of factor VIII
       
17:05-17:25 Belén Pérez Solans Model-based characterization of neutrophil dynamics in children receiving busulfan or treosulfan for hematopoietic stem cell transplant conditioning
       
17:25-18:05 Rare (and other) diseases

Chair: Panos Macheras

       
17:25-17:45 Zinnia Parra-Guillen Disease pharmacokinetic-pharmacodynamic (PKPD) modelling to support the development of gene therapy treatments for rare diseases
       
17:45-18:05 Pascal Chanu A disease progression model for geographic atrophy

 

 

Thursday

 

       
08:30-09:45 Lewis Sheiner Student Session

Chair: Andrew Hooker, Emilie Hénin, Thomas Dorlo

       
08:30-08:55 Moustafa Ibrahim Competing risks analysis of the Finnish diabetes prevention study
       
08:55-09:20 Sebastiaan Goulooze Novel pharmacometric techniques to quantify and prevent iatrogenic withdrawal in children
       
09:20-09:45 Elena Tosca Dynamic Energy Budget (DEB) based models of tumor-in-host growth inhibition and cachexia onset
       
09:45-09:50 Presentation LBS awards
       
       
09:50-09:55 Special announcement
       
       
09:55-11:20 Coffee break, poster and software session I: posters in Group III (with poster numbers starting with III-) are accompanied by their presenter
       
       
11:20-12:25 Regulatory model-informed drug discovery and development

Chair: Aris Dokoumetzidis

       
11:20-12:05 Kristin Karlsson Regulatory model-informed drug discovery and development in EU – News flash and examples
       
12:05-12:25 Sylvie Retout A model-based extrapolation enabled labelling of emicizumab in haemophilia A paediatric patients <1 year old despite lack of clinical data
       
12:25-12:30 ACoP Announcement
       
       
12:30-14:00 Lunch
       
       
12:30-14:00 ISoP Student Community meet-and-greet during lunch
       
       
14:00-15:20 Stuart Beal methodology session

Chair: Emmanuelle Comets and Siv Jönsson

       
14:00-14:20 Theodoros Papathanasiou Model based optimization of dose-finding studies for drug-combinations.
       
14:20-14:40 Antonio Goncalves Model Averaging in viral dynamic models
       
14:40-15:00 Mohammed Cherkaoui Rbati A liver model for chemoprotection against malaria
       
15:00-15:20 Xiao Zhu A cohesive model framework of receptor pharmacology: beyond the Emax model
       
15:20-15:25 WCoP Announcement
       
       
15:25-16:50 Coffee break, poster and software session I: posters in Group IV (with poster numbers starting with IV-) are accompanied by their presenter
       
       
16:50-17:30 Stuart Beal methodology session, continued

Chair: Justin Wilkins

       
16:50-17:10 Alison Margolskee Exploratory graphics (xGx): promoting the purposeful exploration of PKPD data
       
17:10-17:30 Marc Cerou Performance of npde for the evaluation of joint model with time to event data
       
18:30-01:00 Social event
       

 

 

Thursday

 

       
08:30-09:45 Lewis Sheiner Student Session

Chair: Andrew Hooker, Emilie Hénin, Thomas Dorlo

       
08:30-08:55 Moustafa Ibrahim Competing risks analysis of the Finnish diabetes prevention study
       
08:55-09:20 Sebastiaan Goulooze Novel pharmacometric techniques to quantify and prevent iatrogenic withdrawal in children
       
09:20-09:45 Elena Tosca Dynamic Energy Budget (DEB) based models of tumor-in-host growth inhibition and cachexia onset
       
09:45-09:50 Presentation LBS awards
       
       
09:50-09:55 Special announcement
       
       
09:55-11:20 Coffee break, poster and software session I: posters in Group III (with poster numbers starting with III-) are accompanied by their presenter
       
       
11:20-12:25 Regulatory model-informed drug discovery and development

Chair: Aris Dokoumetzidis

       
11:20-12:05 Kristin Karlsson Regulatory model-informed drug discovery and development in EU – News flash and examples
       
12:05-12:25 Sylvie Retout A model-based extrapolation enabled labelling of emicizumab in haemophilia A paediatric patients <1 year old despite lack of clinical data
       
12:25-12:30 ACoP Announcement
       
       
12:30-14:00 Lunch
       
       
12:30-14:00 ISoP Student Community meet-and-greet during lunch
       
       
14:00-15:20 Stuart Beal methodology session

Chair: Emmanuelle Comets and Siv Jönsson

       
14:00-14:20 Theodoros Papathanasiou Model based optimization of dose-finding studies for drug-combinations.
       
14:20-14:40 Antonio Goncalves Model Averaging in viral dynamic models
       
14:40-15:00 Mohammed Cherkaoui Rbati A liver model for chemoprotection against malaria
       
15:00-15:20 Xiao Zhu A cohesive model framework of receptor pharmacology: beyond the Emax model
       
15:20-15:25 WCoP Announcement
       
       
15:25-16:50 Coffee break, poster and software session I: posters in Group IV (with poster numbers starting with IV-) are accompanied by their presenter
       
       
16:50-17:30 Stuart Beal methodology session, continued

Chair: Justin Wilkins

       
16:50-17:10 Alison Margolskee Exploratory graphics (xGx): promoting the purposeful exploration of PKPD data
       
17:10-17:30 Marc Cerou Performance of npde for the evaluation of joint model with time to event data
       
18:30-01:00 Social event
       

 

 

Friday

 

       
09:20-09:40 Oncology

Chair: Ana Ruiz, Siv Jönsson

       
09:20-09:40 Aurelia de Vries Schultink Prospective evaluation of Therapeutic Drug Monitoring of endoxifen: feasibility of observational and randomized trials.
       
09:40-10:00 Coralie Tardivon Association between tumor size kinetics and survival in advanced urothelial carcinoma patients treated with atezolizumab: implication for patient’s follow-up
       
10:00-10:20 Jiajie Yu A new approach to predict PFS in Ovarian Cancer based on tumor growth dynamics.
       
10:20-10:25 Preview of PAGE 2020
       
       
10:25-11:00 Coffee break
       
       
11:00-11:40 Oncology, continued

Chair: Marylore Chenel

       
11:00-11:20 Julie Janssen A semi-physiological framework to predict changes in pharmacokinetics of cytotoxic drugs in pregnant women
       
11:20-11:40 James Lu Integrated efficacy-safety QSP model of acute myeloid leukemia (AML) generates insights into the role of clinical dose schedules on cytopenia
       
11:40-11:50 Closing remarks
       
       
11:50-12:05 Audience input for potential PAGE 2020 topics
       

 

 

Friday

 

       
09:20-09:40 Oncology

Chair: Ana Ruiz, Siv Jönsson

       
09:20-09:40 Aurelia de Vries Schultink Prospective evaluation of Therapeutic Drug Monitoring of endoxifen: feasibility of observational and randomized trials.
       
09:40-10:00 Coralie Tardivon Association between tumor size kinetics and survival in advanced urothelial carcinoma patients treated with atezolizumab: implication for patient’s follow-up
       
10:00-10:20 Jiajie Yu A new approach to predict PFS in Ovarian Cancer based on tumor growth dynamics.
       
10:20-10:25 Preview of PAGE 2020
       
       
10:25-11:00 Coffee break
       
       
11:00-11:40 Oncology, continued

Chair: Marylore Chenel

       
11:00-11:20 Julie Janssen A semi-physiological framework to predict changes in pharmacokinetics of cytotoxic drugs in pregnant women
       
11:20-11:40 James Lu Integrated efficacy-safety QSP model of acute myeloid leukemia (AML) generates insights into the role of clinical dose schedules on cytopenia
       
11:40-11:50 Closing remarks
       
       
11:50-12:05 Audience input for potential PAGE 2020 topics
       
Top